TickerFactsScreenerDevelopers

BIOMARIN PHARMACEUTICAL INC (BMRN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $228.34M2008: $222.90M2009: $167.17M2010: $88.08M2011: $46.27M2012: $180.53M2013: $568.78M2014: $875.49M2015: $397.04M2016: $408.33M2017: $598.03M2018: $493.98M2019: $437.45M2020: $649.16M2021: $587.28M2022: $724.53M2023: $755.13M2024: $942.84M2025: $1.31B$1.31B
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$1.31B+39.1%
2024$942.84M+24.9%
2023$755.13M+4.2%
2022$724.53M+23.4%
2021$587.28M-9.5%
2020$649.16M+48.4%
2019$437.45M-11.4%
2018$493.98M-17.4%
2017$598.03M+46.5%
2016$408.33M+2.8%
2015$397.04M-54.6%
2014$875.49M+53.9%
2013$568.78M+215.1%
2012$180.53M+290.1%
2011$46.27M-47.5%
2010$88.08M-47.3%
2009$167.17M-25.0%
2008$222.90M-2.4%
2007$228.34M—